JJ H. Zhang, MD is a board-certified urologic oncologist in the Department of Urology (academic program). Her clinical practice focuses on surgical management of cancers of the bladder, kidney, prostate, upper urinary tract, testis, and adrenal gland. She is experienced in advanced robotic and laparoscopic as well as open surgical approaches. She employs an evidence-based multidisciplinary approach to patient care and is passionate about optimizing oncologic control while preserving quality of life for her patients. Her research focuses on therapeutic clinical trials in bladder cancer, optimization of outcomes following major urologic surgery, and translational and molecular approaches to precision medicine in urologic cancers. Her prior work has advanced the understanding of healthcare disparities, treatment utilization, and outcomes in bladder cancer, while also contributing important evidence supporting kidney-preservation strategies for patients with complex renal tumors. She is a reviewer for many journals including European Urology and Journal of Urology and has published in high-impact journals including Science and Nature Medicine.

Dr. Zhang graduated Magna Cum Laude and Phi Beta Kappa from UCLA with a degree in Microbiology, Immunology, and Molecular Genetics. She received her medical degree at Duke University School of Medicine with a Dean's Recognition Award and completed Urology residency at the Cleveland Clinic followed by an accredited two-year fellowship in Urologic Oncology at UCLA. Prior to joining Cedars-Sinai she was a high-volume urologic surgeon at Virginia Mason in Seattle where she directed the bladder cancer program, served as director of the multidisciplinary GU Oncology Tumor Board, and served as the site principal investigator of multiple bladder cancer clinical trials.